ScienceMagazine posts bifunctional antibiotic in Science

Science’s X account highlighted a study on September 8 describing a new antibiotic discovery strategy built around “bioinformatic prospecting,” according to the post and the linked paper. The study, published in Science, reported a naturally inspired lipopeptide antibiotic called cilagicin. (science.org) The authors said they identified it through analysis of bacterial biosynthetic gene clusters rather than by isolating a compound directly from a cultured organism. They reported that the molecule combined two antibacterial actions and showed no detectable resistance in laboratory testing. ### What did the researchers say they found? (science.org) Zongqiang Wang, Bimal Koirala, Yozen Hernandez, Matthew Zimmerman and Sean F. Brady reported “the discovery of a naturally inspired lipopeptide antibiotic called cilagicin,” according to the Science paper. The authors said they chemically synthesized the compound after a “detailed bioinformatic analysis” of the underlying biosynthetic gene cluster. The paper said the search focused on uncharacterized biosynthetic gene clusters in bacterial genome-sequencing datasets. The authors wrote that such clusters remain an “appealing source of antibiotics with distinctive modes of action” because much of bacterial biosynthetic capacity has remained silent in earlier discovery efforts. (science.org) ### How was “bioinformatic prospecting” used here? The study said the team used phylogenetic analysis of condensation starter domain sequences to identify what it called the cryptic cil biosynthetic gene cluster. The authors said they collected nonribosomal peptide synthetase biosynthetic gene clusters from about 10,000 sequenced bacterial genomes as part of that search. (science.org) The paper said the goal was to find lipopeptide antibiotics with distinctive mechanisms of action. Instead of relying on standard cultivation to induce production of a natural product, the researchers inferred a candidate structure from genomic information and then synthesized the molecule. (science.org) ### What makes cilagicin “bifunctional”? The Science paper said cilagicin can “sequester two distinct, indispensable undecaprenyl phosphates used in cell wall biosynthesis.” The authors presented that dual targeting as the basis for describing the molecule as bifunctional. (science.org) Undecaprenyl phosphate carriers are required for building the bacterial cell wall, according to the paper. By binding two distinct versions involved in that process, cilagicin was reported to interfere with an essential pathway at two points rather than one. That is the core claim behind the study’s low-resistance framing. (science.org) ### What did the paper say about resistance? The authors said cilagicin showed an “absence of detectable resistance in laboratory tests and among multidrug-resistant clinical isolates.” The paper described that finding as one reason the compound could be an “appealing candidate for combating antibiotic-resistant pathogens.” (science.org) The study’s wording is narrower than a claim that resistance cannot emerge. The paper reported what the researchers observed in their assays and screens, not a clinical outcome in patients. ### What should readers be careful not to overread? (science.org) Science published the study as a research paper, not as a drug approval or late-stage clinical trial result. The paper described discovery, synthesis and preclinical characterization of cilagicin, with resistance findings limited to laboratory tests and analyses cited by the authors. The authors framed the work as a way to replenish antibiotic pipelines by mining uncharacterized bacterial gene clusters for molecules with new mechanisms. (science.org) That makes the paper as much a discovery-method report as a single-compound announcement. ### Where does the story go next? The Science paper identifies cilagicin as the lead molecule and names Wang, Koirala, Hernandez, Zimmerman and Brady as the study authors. The next concrete reference point for readers is the published Science article and its supplementary materials, which set out the discovery method, synthesis and resistance testing in detail. (science.org)